Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China · Delayed Price · Currency is CNY 38.11
-0.75 (-1.93%)
Jul 21, 2026, 3:00 PM CST
SHA:600329 Market Cap
SHA:600329 has a market cap or net worth of 25.95 billion as of July 21, 2026. Its market cap has increased by 6.53% in one year.
Market Cap
25.95B
Enterprise Value
24.24B
Revenue
4.98B
Ranking
n/a
PE Ratio
13.74
Stock Price
38.11
ChartMarket Cap Chart
Since June 6, 2001, SHA:600329's market cap has increased from 6.92B to 25.95B, an increase of 275.20%. That is a compound annual growth rate of 5.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 25.95B | -15.70% |
| Dec 31, 2025 | 30.78B | 48.69% |
| Dec 31, 2024 | 20.70B | -6.43% |
| Dec 29, 2023 | 22.12B | 21.24% |
| Dec 30, 2022 | 18.25B | -6.30% |
| Dec 31, 2021 | 19.47B | 73.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Changchun High-Tech Industry (Group) | 29.53B |
| Shijiazhuang Yiling Pharmaceutical | 29.40B |
| Humanwell Healthcare (Group) | 28.87B |
| Dizal (Jiangsu) Pharmaceutical | 28.57B |
| Livzon Pharmaceutical Group | 25.25B |
| Zhejiang Huahai Pharmaceutical | 24.69B |
| Betta Pharmaceuticals | 24.36B |
| Hubei Jumpcan Pharmaceutical | 24.19B |